400 filings
Page 5 of 20
8-K
vvp82btof0zy2q xk89
28 Jul 20
Zynex Announces Second Quarter 2020 Earnings
4:10pm
8-K
j73lj ykidi6ca914u7
17 Jul 20
Zynex, Inc. Prices Public Offering of Common Stock
4:30pm
424B5
pqk5rr5kpsh 5s6cjy8
16 Jul 20
Prospectus supplement for primary offering
9:01am
424B7
jnrgg 6472r
16 Jul 20
Prospectus with selling stockholder info
9:00am
424B5
86tnh6sp94h2gd165ma
14 Jul 20
Prospectus supplement for primary offering
5:01pm
424B7
wcz8v73lo9zowudtqus
14 Jul 20
Prospectus with selling stockholder info
4:59pm
8-K
3wntfu2seuh
13 Jul 20
Zynex Announces 37% Order Growth and Increases Q2 and Full-Year Revenue Estimates
8:01am
8-K
m3ftk4 rgi4716o
21 May 20
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
sr6z4fwqxuk4adyxaqi
5 May 20
Other Events
9:25am
8-K
2fk5l78i1xb5mx9j2qn
28 Apr 20
Zynex Announces 2020 First Quarter Earnings
4:15pm
DEFA14A
nmx0gp722qibcnf
2 Apr 20
Additional proxy soliciting materials
4:23pm
DEF 14A
6a3ig0vh
2 Apr 20
Definitive proxy
4:15pm
8-K
zx7ozvyvrd2l0hu8h8z
27 Feb 20
Zynex Announces 2019 Fourth Quarter and Full Year Earnings
12:00am
8-K
kh4an5wfchui0
25 Feb 20
Zynex Receives FDA Clearance for its Blood Volume Monitor
4:00pm
8-K
5jmu8co9
7 Jan 20
Zynex Expands Corporate Headquarters to Accommodate Growth
4:00pm
8-K
a9xdpa 55bf95mxk2
30 Oct 19
Zynex Announces 2019 Third Quarter Financial Results
12:00am
424B5
5ijvaum
29 Oct 19
Prospectus supplement for primary offering
5:19pm
8-K
sv63ad
29 Oct 19
Entry into a Material Definitive Agreement
5:11pm